A Los Angeles-area pharmaceutical company is planning to build a major pharmaceutical manufacturing and research facility outside of Madison where it will invest up to $250 million and create 250 jobs.
Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) of Pasadena, California, said recently it has completed the purchase of 13 acres in the Verona Technology Park in Verona. The site is planned for an approximately 140,000-square-foot drug manufacturing facility and an approximately 115,000-square-foot laboratory and office facility to support process development and analytical activities.
Arrowhead intends to invest between $200 million and $250 million into the buildout of the facilities. It expects that the new facilities will result in the creation of about 250 new jobs in the area. News of the facility first emerged in early fall when the company filed a proposal with the Plan Commission for the city of Verona, which is home to other high-tech companies like Epic Systems Corp. and MilliporeSigma.